Literature DB >> 10491311

Prevention of endotoxin-induced lethality, but not of liver apoptosis in poly(ADP-ribose) polymerase-deficient mice.

S Kühnle1, P Nicotera, A Wendel, M Leist.   

Abstract

Activation of poly-(ADP-ribose) polymerase (PARP) is often associated with cytotoxicity, but its precise role in shock-induced lethality and in different modes of tissue injury is still unknown. We took advantage of the existence of mice with a targeted deletion of the PARP gene (PARP-/-) to examine the differential sensitivity of wild-type (wt) and PARP-/- mice toward endotoxin (LPS)-induced lethality and different forms of liver damage. All PARP-/- animals survived high-dose (20 mg/kg) LPS-mediated shock, which killed 60% of wt animals. Moreover, LPS-induced necrotic liver damage was significantly reduced. In contrast, when apoptotic liver damage was induced via injection of low concentrations of LPS (30 microgram/kg) into D-galactosamine-sensitized mice, or via activation of hepatic cell death receptors, PARP-/- animals were not protected. We conclude that PARP is involved in systemic LPS toxicity, while it plays a minor role in apoptotic liver damage mediated by TNF or CD95. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10491311     DOI: 10.1006/bbrc.1999.1393

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  12 in total

1.  Inhibitors of poly(ADP-ribose) polymerase-1 suppress transcriptional activation in lymphocytes and ameliorate autoimmune encephalomyelitis in rats.

Authors:  Alberto Chiarugi
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

2.  Poly(ADP-ribose) polymerase-1 is required for efficient HIV-1 integration.

Authors:  H C Ha; K Juluri; Y Zhou; S Leung; M Hermankova; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-06       Impact factor: 11.205

3.  Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages.

Authors:  Wei Jiang; Rui Sun; Haiming Wei; Zhigang Tian
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-15       Impact factor: 11.205

Review 4.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.

Authors:  Yan Zhang; Ha-Jeong Kim; Soichiro Yamamoto; Xiaoyan Kang; Xiaojing Ma
Journal:  J Interferon Cytokine Res       Date:  2010-03       Impact factor: 2.607

5.  Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia.

Authors:  Hyo Chol Ha; Lynda D Hester; Solomon H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

6.  Noncleavable poly(ADP-ribose) polymerase-1 regulates the inflammation response in mice.

Authors:  Virginie Pétrilli; Zdenko Herceg; Paul O Hassa; Nimesh S A Patel; Rosanna Di Paola; Ulrich Cortes; Laura Dugo; Helder-Mota Filipe; Christoph Thiemermann; Michael O Hottiger; Salvatore Cuzzocrea; Zhao-Qi Wang
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

7.  Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.

Authors:  C M Simbulan-Rosenthal; D S Rosenthal; R Luo; J H Li; J Zhang; M E Smulson
Journal:  Nucleic Acids Res       Date:  2001-02-01       Impact factor: 16.971

Review 8.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

9.  Nicotinamide is a potent inhibitor of proinflammatory cytokines.

Authors:  J S Ungerstedt; M Blömback; T Söderström
Journal:  Clin Exp Immunol       Date:  2003-01       Impact factor: 4.330

10.  Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner.

Authors:  Frédéric Van Gool; Mara Gallí; Cyril Gueydan; Véronique Kruys; Pierre-Paul Prevot; Antonio Bedalov; Raul Mostoslavsky; Frederick W Alt; Thibaut De Smedt; Oberdan Leo
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.